Jessica Chubak, PhD

Chubak_Jessica__205x293.jpg

“My research focuses on improving cancer control by finding effective ways to get screened for cancer and to navigate treatment and survivorship.”

Jessica Chubak, PhD

Senior Investigator, Kaiser Permanente Washington Health Research Institute

Biography

Jessica Chubak, PhD, is an epidemiologist who works to improve cancer diagnosis, treatment, control, and survivorship. She contributes to several national collaborations that are finding practical, efficient, effective ways to screen for cancer, especially colorectal cancer. She also studies how common medications affect cancer risk and recurrence. Intrigued by how pets positively affect health, Dr. Chubak is studying animal-assisted activities in clinics and hospitals where children get treated for cancer. Dr. Chubak’s methodological research focuses on the use of administrative and electronic health record data in epidemiologic and health services studies.

Dr. Chubak joined KPWHRI in 2007, bringing expertise in epidemiologic methods, pharmacoepidemiology, and cancer. Awarded a Fulbright graduate student grant, Dr. Chubak pursued her master's degree in bioethics and health law in New Zealand before completing her PhD in Epidemiology at the University of Washington (UW). Dr. Chubak is an affiliate associate professor in the Department of Epidemiology at the UW School of Public Health, where she enjoys guest-lecturing and getting to work with students.

Research interests and experience

 

Recent publications

Carrell DS, Halgrim S, Tran DT, Buist DS, Chubak J, Chapman WW, Savova G. Using natural language processing to improve efficiency of manual chart abstraction in research: the case of breast cancer recurrence. Am J Epidemiol. 2014 Mar 15;179(6):749-58. doi: 10.1093/aje/kwt441. Epub 2014 Jan 30. PubMed

Carrell DS, Halgrim S, Tran DT, Buist DS, Chubak J, Chapman WW, Savova G. Carrell et al. respond to "Observational research and the EHR." Am J Epidemiol. 2014 Mar 15;179(6):762-3. doi: 10.1093/aje/kwt444. Epub 2014 Jan 30. PubMed

Laing SS, Bogart A, Chubak J, Fuller S, Green BB. Psychological distress after a positive fecal occult blood test result among members of an integrated healthcare delivery system. Cancer Epidemiol Biomarkers Prev. 2014 Jan;23(1):154-9. doi: 10.1158/1055-9965.EPI-13-0722. Epub 2013 Nov 12. PubMed

Chubak J, Aiello Bowles EJ, Tuzzio L, Ludman E, Rutter CM, Reid RJ, Wagner EH. Perspectives of cancer survivors on the role of different healthcare providers in an integrated delivery system. J Cancer Surviv. 2014 Jun;8(2):229-38. doi: 10.1007/s11764-013-0335-1. Epub 2013 Dec 19. PubMed

Wagner EH, Ludman EJ, Aiello Bowles EJ, Penfold R, Reid RJ, Rutter CM, Chubak J, McCorkle R. Nurse navigators in early cancer care: a randomized, controlled trial. J Clin Oncol. 2014 Jan 1;32(1):12-8. doi: 10.1200/JCO.2013.51.7359. Epub 2013 Nov 25. PubMed

Chubak J, Bogart A, Fuller S, Laing SS, Green BB. Uptake and positive predictive value of fecal occult blood tests: a randomized controlled trial. Prev Med. 2013 Nov;57(5):671-8. doi: 10.1016/j.ypmed.2013.08.032. Epub 2013 Sep 9. PubMed

Hamilton JG, Birmingham WS, Tehranifar P, Irwin ML, Klein WM, Nebling L, Chubak J. Transitioning to independence and maintaining a career in the new funding climate: a report from the American Society of Preventive Oncology’s Junior Members Interest Group. Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):2138-42. doi: 10.1158/1055-9965.EPI-13-0807. PubMed

 

healthy findings

Data-analysis_1col.jpg

Ask an epidemiologist: Where to learn about COVID-19

There’s much confusion about the new disease, but numbers don’t lie. The challenge is finding the right ones.

innovating care

Fit-Kit-Colon-testing_1col.jpg

How to maximize screening for colon cancer

Research informs care as Kaiser Permanente Washington, exceeding 80 percent screening rate, launches home-based 'FIT First' pilot.

Read about it in News and Events.

Cancer Research

PROSPR-blog_1col.jpg

Research funded to improve cancer screening

Drs. Kamineni and Chubak are among leaders of 2 new large PROSPR awards from NCI for cervical and colorectal cancer screening research.

Read it in News and Events.